JeanMarie Guenot has worked in the pharmaceutical and biotechnology industry for the past twenty years. JeanMarie is the President and CEO of the San-Francisco-based oncology institute, Amphivena Therapeutics Inc. The enterprise specializes in coming up with new antibody treatments targeting hematological malignancies in cells.
Previously, the CEO of Amphivena served as the founder and president of a pharmaceutical startup venture called SKS Ocular. SKS Ocular primary agenda is to become the premier developer of safe, efficient and pocket-friendly therapies against glaucoma, eye inflammations, and macular dystrophy. The refined business acumen of this woman helped transform SKS from an obscure startup to one of the nation’s most scientifically advanced medical research and drug development centers.
Uniqueness must be JeanMarie’s middle name because you are not going to find many big pharmaceutical CEOs having the combination of a scientific and a capitalist background on crunchbase.com. Mostly, these companies either choose to have a professional with an advanced medical education or an Executive MBA trained from Harvard.
Venture Capitalism Days
Dr. JeanMarie used to be one of the lead consultants over at the prestigious Swiss hedge fund investment firm, Hoffmann-La Roche. Her portfolio was mostly composed of assets and opportunities in the Asia-Pacific region, notably Shanghai, China. Later she moved on to work at PLC Bio-Pharmaceutical firm as the organization’s V.P in charge of Corporate and Business Development. Here her core duties and responsibilities included:-
• Overseeing mergers and acquisitions
• Ensuring licensing and compliance issues
• Streamlining under-performing departments
• Raising research capital with key development partners
Racing for the Cure
Her stint at the pharma giant ranks as one of the milestone achievement of the résumé of Dr. Guenot. But, it was her tenure as the lead scientist the R&D department of Hoffmann-La Roche which forever changed her life. For the first time, she realized how it possible for her to change the world and make it a better place for everyone. To accomplish her noble pursuit, she’s had to use her skills and professional connections to make sure potential therapies and treatments for autoimmune diseases and cancer get to live to see the light of day.
About JeanMarie Guenot
Dr. Guenot is a leading American business leader and an oncology researcher. She attended the Atlas Venture institute to hone and perfect her financial intelligence and investment skills. To-date, the scientist is responsible for nurturing and building several established corporations in the US and abroad. The seasoned researcher holds a Ph.D. from the University of California and an MBA certification courtesy of the University of Pennsylvania.
Learn more about Jeanmarie Guenot: http://www.guenotllc.com/Biography.html